|
Synonyms: hPMAb22 [3] | PBP-1510 | PBP1510
Compound class:
Antibody
Comment: The INN record for ulenistamab identifies this as a hunamised monoclonal antibody directed against a protein called pancreatic adenocarcinoma up-regulated factor (PAUF). PAUF appears to be a product of the zymogen granule protein 16B gene ZG16B (UniProt accession Q96DA0), that is aberrantly expressed in some cancers [1,4], and which is involved in tumour development and metastasis [2]. The peptide sequences of the heavy and light chains of ulenistamab are claimed in patent WO2019022281A1 [3].
|
Classification  |
|
| Compound class | Antibody |
| International Nonproprietary Names |
|
| INN number | INN |
| 11699 | ulenistamab |
| Synonyms |
|
| hPMAb22 [3] | PBP-1510 | PBP1510 | |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 1176 |
| Other databases | |
| GtoPdb PubChem SID | 458923806 |
| Search PubMed clinical trials | ulenistamab |
| Search PubMed titles | ulenistamab |
| Search PubMed titles/abstracts | ulenistamab |
